GUCCIONE, GIORGIA
 Distribuzione geografica
Continente #
EU - Europa 245
AS - Asia 99
NA - Nord America 57
SA - Sud America 6
AF - Africa 1
Totale 408
Nazione #
IT - Italia 223
US - Stati Uniti d'America 55
SG - Singapore 40
CN - Cina 29
VN - Vietnam 18
FR - Francia 6
BR - Brasile 5
JP - Giappone 5
DE - Germania 4
BD - Bangladesh 3
GB - Regno Unito 3
BE - Belgio 2
CA - Canada 2
FI - Finlandia 2
MN - Mongolia 2
UA - Ucraina 2
AR - Argentina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
HK - Hong Kong 1
PT - Portogallo 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 408
Città #
Genoa 167
Vado Ligure 36
Singapore 16
San Jose 14
Milan 12
Sacramento 8
Brooklyn 5
Ashburn 4
Beijing 4
Hanoi 4
Council Bluffs 3
Frankfurt am Main 3
Antwerp 2
Coventry 2
Des Moines 2
Helsinki 2
Ho Chi Minh City 2
La Seyne-sur-Mer 2
Marseille 2
Santa Clara 2
Toronto 2
Tujunga 2
Turin 2
Ulan Bator 2
Arvada 1
Can Tho 1
Canton 1
Caratinga 1
Catania 1
Charlotte 1
Chicago 1
Comano 1
Curado 1
Curitiba 1
Da Nang 1
Fuzhou 1
Guimarães 1
Hamburg 1
Hong Kong 1
Houston 1
Hurlingham 1
Jingmen 1
Johannesburg 1
Kyiv 1
Kōriyama 1
Los Angeles 1
Manaus 1
Ninh Bình 1
Paris 1
Phủ Lý 1
Piscataway 1
Prague 1
Salt Lake City 1
Saquarema 1
Suzhou 1
Tokyo 1
Uzhhorod 1
Totale 333
Nome #
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays 125
Tackling the NAD-­related signaling pathways to counteract doxorubicin-induced cardiotoxicity 68
Elucidating new aspects of nicotinamide mononucleotide (NMN) therapeutic mechanism 52
Tackling the NAD-related signaling pathways to counteract doxorubicin-induced cardiotoxicity 46
Tackling the NAD-related signaling pathways to counteract doxorubicin-induced cardiotoxicity 45
Boosting NAD+ pathways to counteract Doxorubicin-induced cardiotoxicity 44
Tackling The NAD-Related Signaling Pathways To Counteract Doxorubicin-Induced Cardiotoxicity 40
Totale 420
Categoria #
all - tutte 929
article - articoli 260
book - libri 0
conference - conferenze 615
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.804


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025108 0 0 10 4 13 19 9 11 4 9 13 16
2025/2026312 20 6 29 46 38 11 39 29 32 62 0 0
Totale 420